(Reuters) - Canada’s main stock index rose on Monday, as energy stocks jumped 3% tracking oil prices, after U.S. drugmaker Moderna Inc said its experimental vaccine was 94.5% effective in preventing COVID-19.
Moderna Inc MRNA.O became the second U.S. company in a week to report positive results from its COVID-19 vaccine trial, which raised hopes of a quicker economic recovery from a pandemic-led recession.
Adding to the upbeat mood, Canada’s factory sales increased by 1.5% in September from August on higher sales in the wood industry, as well as the chemical industry, Statistics Canada said.
At 9:41 a.m. ET (1441 GMT), the Toronto Stock Exchange's S&P/TSX composite index .GSPTSE was up 60.24 points, or 0.36%, at 16,735.88.
The materials sector .GSPTTMT, which includes precious and base metals miners, lost 0.5% as gold prices fell.
Fortuna Silver Mines Inc FVI.TO fell 4.9%, the most on the TSX, after Canaccord Genuity downgraded the stock
On the TSX, 137 issues were higher, while 84 issues declined for a 1.63-to-1 ratio favouring gainers, with 29.95 million shares traded.
H&R Real Estate Investment Trust HR_u.TO rose 5.7% after TD Securities raised its price target on the real estate investment trust's stock.
The TSX posted four new 52-week highs and no new low.
Across all Canadian issues there were 52 new 52-week highs and three new lows, with total volume of 53.36 million shares.
Reporting by Amal S in Bengaluru; Editing by Amy Caren Daniel
Our Standards: The Thomson Reuters Trust Principles.